Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
The Journal of Urology|December 13, 2002
Predicting recurrence after radical prostatectomy for patients with high risk prostate cancerGary D Grossfeld, David M Latini, Deborah P Lubeck, et al.
Urology|May 7, 2002
Utility of intraoperative frozen section analysis of surgical margins in region of neurovascular bundles at radical prostatectomyReza Z Goharderakhshan, Daniel Sudilovsky, Lauren A Carroll, et al.
The Journal of Urology|May 2, 2019
Emerging Immunotherapy Options for bacillus Calmette-Guérin Unresponsive Nonmuscle Invasive Bladder CancerMaxwell V Meng, Jürgen E Gschwend, Neal Shore, et al.
The Journal of Urology|November 21, 2002
Is ethnicity an independent predictor of prostate cancer recurrence after radical prostatectomy?Gary D Grossfeld, David M Latini, Tracy Downs, et al.
Urology|September 17, 2002
Contemporary patterns of androgen deprivation therapy use for newly diagnosed prostate cancerMaxwell V Meng, Gary D Grossfeld, Natalia Sadetsky, et al.
The Journal of Urology|February 10, 2004
Treatment and outcome of invasive bladder cancer in patients after renal transplantationViraj A Master, Maxwell V Meng, Gary D Grossfeld, et al.
The Journal of Urology|March 26, 2002
How well does the Partin nomogram predict pathological stage after radical prostatectomy in a community based population? Results of the cancer of the prostate strategic urological research endeavorDavid F Penson, Gary D Grossfeld, Yu-Ping Li, et al.
The Journal of Urology|July 20, 2002
Predictors of secondary cancer treatment in patients receiving local therapy for prostate cancer: data from cancer of the prostate strategic urologic research endeavorGary D Grossfeld, Yu-Ping Li, Deborah P Lubeck, et al.
Urology|January 18, 2002
Thrombospondin-1 expression in patients with pathologic stage T3 prostate cancer undergoing radical prostatectomy: association with p53 alterations, tumor angiogenesis, and tumor progressionGary D Grossfeld, Peter R Carroll, Neil Lindeman, et al.
Urology|February 1, 2003
How potent is potent? Evaluation of sexual function and bother in men who report potency after treatment for prostate cancer: data from CaPSUREMatthew R Cooperberg, Theresa M Koppie, Deborah P Lubeck, et al.
Pageof 3